• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA22-80/I16-40
Device Problems Collapse (1099); Hole In Material (1293); Leak/Splash (1354); Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017); Patient-Device Incompatibility (2682); Device Damaged by Another Device (2915)
Patient Problems Aneurysm (1708); Death (1802); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914); Failure of Implant (1924); Renal Failure (2041); Shock (2072); Rupture (2208)
Event Date 08/25/2017
Event Type  Injury  
Manufacturer Narrative
To date, the incident device has not been received for evaluation.If the sample is received or if additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted to treat a small abdominal aortic aneurysm with aortic iliac occlusive disease (aiod).In addition to the bifurcated stent, the physician implanted two kissing stents in the right and left common iliac arteries.The patient is reported to have calcification in the aortic neck.The physician performed post dilation of the implanted devices by use of aggressive ballooning and a final angiogram revealed a ruptured aorta and a possible type 3b endoleak of the main body device.The physician implanted a second bifurcated stent to resolve the issue.The procedure was completed and the patient was reported to be in stable condition.The patient was sent to the intensive care unit (icu) where they later expired.The cause of death was not reported to endologix.
 
Manufacturer Narrative
(b)(4).Clinical review found evidence to reasonably suggest the following factors contributed to the reported event: off-label usage, pre-existing endoleak type ia at implant, pre-existing aortic dissection, increase in the infrarenal aortic angulation, and increased angulation of the left iliac limb at the bifurcation.The manufacturing evaluation did not reveal any issues or deviations that would explain the reported event.The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned, therefore no physical evaluation was completed.
 
Manufacturer Narrative
The devices remain implanted in the patient and was not returned for device evaluation.Based on the information received, clinical evaluation confirmed the reported type 3b endoleak, rupture and patient death.Clinical evaluation refuted the reported cardiac-related death, determining the death was caused by the intra-operative rupture; hemorrhage and shock.The most likely cause of compromised stent graft integrity could not be determined due to the lack of available medical images surrounding the implant procedure.However, procedure-related ballooning in an off-label, calcified iliac anatomy likely contributed to this device failure (intentional user error).The extra angioplasty required to treat the first main body stent likely contributed to the intra-operative negative sequalae (procedure-related issue).Notably, the off-label use of non endologix products and the pre-existing iliac tortuosity and calcification (cautionary product use conditions) might also have contributed to this event.Associated clinical harms for this device failure included: type iiib endoleak of the first main body stent; intra-operative rupture; hemorrhage; hemodynamic instability (shock), death on the operative day.No procedure-related harms were detected due to the persistent of intra-operative instability.The lot usage history shows that no other units from the affected lot has been involved in any similar complaints at this time.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key6689325
MDR Text Key87153458
Report Number2031527-2017-00486
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009015006
UDI-Public(01)00818009015006(17)180607
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 01/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/07/2018
Device Model NumberBEA22-80/I16-40
Device Lot Number1701103-008
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/25/2017
Initial Date FDA Received07/06/2017
Supplement Dates Manufacturer Received08/25/2017
08/25/2017
Supplement Dates FDA Received07/06/2017
03/06/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AFX2 BIFURCATED STENT GRAFT LOT - 1668623020
Patient Outcome(s) Death;
Patient Age86 YR
Patient Weight77
-
-